Oral contraceptives and primary liver cancer
- PMID: 2930715
- PMCID: PMC2247061
- DOI: 10.1038/bjc.1989.94
Oral contraceptives and primary liver cancer
Abstract
PIP: The relative risk for developing primary liver cancer in northern Italian users of oral contraceptives, compared to matched controls was calculated based on reported cases in hospitals in the greater Milan area from 1984-1987. The incidence of and mortality from primary liver cancer, as well as the prevalence of oral contraceptive usage, have both been rising to Italy since the late 1950s. 21 cases of liver cancer, in women aged 32-59 (median 50), occurred in the Milan area during the study period. These women, and 145 controls matched for age but admitted to hospitals for a variety of non-neoplastic diseases, were interviewed with a structured questionnaire covering socio-demographics, life style, diet, medical history, and history of use of oral contraceptives and other drugs. 19.0% of the cases had used oral contraceptives compared to 7.6% of controls, a relative risk of 1.8 for up to 5 years' use, and 8.3 for 5 years. History of hepatitis was associated with 14% of cases and 7% of controls. Italians have a higher incidence of liver neoplasms that northern Europeans and Americans, probably because of higher incidence of risk factors, such as hepatitis and alcohol use. The attributable risk for oral contraception, however, is lower in this population.
Similar articles
-
Female hormone utilisation and risk of hepatocellular carcinoma.Br J Cancer. 1993 Mar;67(3):635-7. doi: 10.1038/bjc.1993.116. Br J Cancer. 1993. PMID: 8382515 Free PMC article.
-
Oral contraceptives as related to cancer and benign lesions of the breast.J Natl Cancer Inst. 1975 Oct;55(4):767-73. doi: 10.1093/jnci/55.4.767. J Natl Cancer Inst. 1975. PMID: 1185801
-
Oral contraceptive use and invasive cervical cancer.Int J Epidemiol. 1990 Jun;19(2):259-63. doi: 10.1093/ije/19.2.259. Int J Epidemiol. 1990. PMID: 2376433
-
The risk of liver neoplasia in relation to combined oral contraceptive use.Contraception. 1991 Jun;43(6):643-52. doi: 10.1016/0010-7824(91)90007-3. Contraception. 1991. PMID: 1651205 Review.
-
Oral contraceptives and life expectancy.Stud Fam Plann. 1986 May-Jun;17(3):117-25. Stud Fam Plann. 1986. PMID: 3523849 Review.
Cited by
-
Effect of oestrogen/gestagen replacement therapy on liver enzymes in patients with Ullrich-Turner syndrome.Eur J Pediatr. 1995 Oct;154(10):807-10. doi: 10.1007/BF01959786. Eur J Pediatr. 1995. PMID: 8529677
-
Cancer mortality in young adults: Italy 1955-1985.J Cancer Res Clin Oncol. 1990;116(2):215-9. doi: 10.1007/BF01612680. J Cancer Res Clin Oncol. 1990. PMID: 2324166 Free PMC article.
-
Risk for malignant tumors after oral contraceptive use: is it related to organ size while taking the pill?Med Oncol Tumor Pharmacother. 1990;7(1):61-4. doi: 10.1007/BF03000492. Med Oncol Tumor Pharmacother. 1990. PMID: 2187124 Review. No abstract available.
-
Trends in mortality from primary liver cancer in England and Wales 1975-92: influence of oral contraceptives.Br J Cancer. 1995 Sep;72(3):800-3. doi: 10.1038/bjc.1995.415. Br J Cancer. 1995. PMID: 7669599 Free PMC article.
-
Etiology of primary liver cancer and the role of steroidal hormones.Cancer Causes Control. 1992 Jan;3(1):3-5. doi: 10.1007/BF00051905. Cancer Causes Control. 1992. PMID: 1311211 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical